Literature DB >> 8051160

Androgen and glucocorticoid receptors interact with insulin degrading enzyme.

S R Kupfer1, E M Wilson, F S French.   

Abstract

We recently identified a protein, designated receptor accessory factor (RAF), that interacts directly with and enhances the DNA binding of androgen (AR) and glucocorticoid (GR) receptor peptide fragments. To determine its identity, RAF was purified from HeLa cell extracts by anion-exchange and DNA affinity chromatography. RAF activity co-purified with a 110-kDa protein, the partial amino acid sequence of which shares 97.5% identity with insulin degrading enzyme (IDE), a metalloendoprotease implicated in the intracellular degradation of insulin. The identity of RAF was confirmed in gel shift assays by demonstrating that AR.RAF and GR.RAF DNA complexes shifted to a slower mobility in the presence of an IDE antibody. Purified preparations of RAF had insulin degrading activity, and this activity was inhibited by AR. In addition, the interaction of AR or GR with RAF was competed by insulin and bacitracin, a competitive inhibitor of IDE. The interactions of AR and GR with IDE may have important implications for both insulin- and steroid-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051160

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Identification of two novel cis-elements in the promoter of the prostate-specific antigen gene that are required to enhance androgen receptor-mediated transactivation.

Authors:  J Zhang; S Zhang; P E Murtha; W Zhu; S S Hou; C Y Young
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 2.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

3.  Hyperglycaemia and hyperinsulinaemia: is insulin-degrading enzyme the missing link?

Authors:  J Fawcett; W C Duckworth
Journal:  Diabetologia       Date:  2009-06-06       Impact factor: 10.122

Review 4.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

5.  II - Insulin processing in mitochondria.

Authors:  María Del Carmen Camberos; Adriana A Pérez; Gisel A Passicot; Lucía C Martucci; María I Wanderley; Daniel P Udrisar; Juan C Cresto
Journal:  J Bioenerg Biomembr       Date:  2016-10-29       Impact factor: 2.945

6.  Anion activation site of insulin-degrading enzyme.

Authors:  Nicholas Noinaj; Eun Suk Song; Sonia Bhasin; Benjamin J Alper; Walter K Schmidt; Louis B Hersh; David W Rodgers
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

7.  Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

Authors:  A Pérez; L Morelli; J C Cresto; E M Castaño
Journal:  Neurochem Res       Date:  2000-02       Impact factor: 3.996

8.  Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.

Authors:  O Pivovarova; O Gögebakan; A F H Pfeiffer; N Rudovich
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

9.  Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria.

Authors:  Malcolm A Leissring; Wesley Farris; Xining Wu; Danos C Christodoulou; Marcia C Haigis; Leonard Guarente; Dennis J Selkoe
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

10.  Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.

Authors:  Mark A Reger; G Stennis Watson; Pattie S Green; Laura D Baker; Brenna Cholerton; Mark A Fishel; Stephen R Plymate; Monique M Cherrier; Gerard D Schellenberg; William H Frey; Suzanne Craft
Journal:  J Alzheimers Dis       Date:  2008-04       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.